Related Experiment Video
Updated: Nov 22, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Balance Problems, Paralysis, and Angina as Clinical Markers for Severity in Major Depression
Bill Qi1, Kellie MacDonald1, Marcelo T Berlim2
1Department of Human Genetics, McGill University, Montreal, QC, Canada.
Neurological symptoms like muscular paralysis and balance problems significantly increase with major depressive disorder (MDD) severity. These findings suggest clinical history could help monitor depression.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Medicine
Background:
- Major depressive disorder (MDD) is a complex and heterogeneous condition.
- Understanding factors correlating with depression severity is crucial for effective patient management.
- Neurological symptoms are not always considered in routine MDD assessments.
Purpose of the Study:
- To investigate the correlation between specific neurological symptoms and the severity of major depressive disorder.
- To identify potential clinical biomarkers for assessing depression severity in outpatients.
Main Methods:
- One hundred eighty-four outpatients with MDD completed self-report questionnaires.
- Patients were stratified into low, medium, and high depression severity groups based on the APA Severity Measure for Depression-Adult.
- Binary logistic regression was used to analyze the association between clinical variables and depression severity.
Main Results:
- A significant, gradual increase in the frequency of muscular paralysis and balance problems was observed with increasing MDD severity.
- High severity MDD patients reported higher rates of angina symptoms compared to low severity patients.
- Muscular paralysis (OR 13.5) and balance problems (OR 2.9) were significantly associated with increased depression severity.
Conclusions:
- Neurological symptoms, specifically muscular paralysis and balance problems, are strongly correlated with major depressive disorder severity.
- Clinical history and neurological examination may serve as valuable, accessible biomarkers for monitoring depression.
- These findings support the potential development of a simple clinical scale for regular MDD patient monitoring.
More Related Videos
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
04:38A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Related Concept Videos
Angina III: Clinical Manifestations and Assessment
Coronary Artery Disease III: Clinical Manifestations
Depressive Disorders: MDD and Dysthymia
Measurement of Blood Pressure
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina V: Nursing Management